Skip to main content

Table 7 Comparison between HBV DNA PCR results in the studied patients

From: Study of hepatitis B virus infection, reactivation among patients with chronic hepatitis C infection treated by direct antiviral agents (DAAs)

N = 15 At the start of treatment 1 month of treatment At the end of treatment P-value
HBV DNA PCR
Negative 12 (80%) 5 (33.3%) 0 (0%) P1 = 0.009 HS
P2 < 0.001 HS
P3 = 0.014 S
Positive 3 (20%) 10 ( 66.7%) 15 (10%)
  1. X2: chi-square test
  2. S: p-value < 0.05 is considered significant
  3. HS: p-value < 0.001 is considered highly significant
  4. P1: refers to the statistical difference between the start of DAA and 1 month after DAA
  5. P2: refers to the statistical difference between the start of DAA and the end of DAA
  6. P3: refers to the statistical difference between 1 month after DAA and the end of DAA